Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

HLB Innovation acquires HLB Cell for therapy hub

PRIVATESep 09, 2026about 2 hours ago

Acquiring Company

HLB Innovation

Acquired Company

HLB Cell

South KoreaBiotechnologyHealth CareBiotechnologyHealth CareTherapeutics

Description

HLB Innovation has acquired HLB Cell to strengthen its domestic capabilities in cell therapy. This acquisition emphasizes HLB Innovation's commitment to advancing healthcare solutions. By integrating HLB Cell, the company aims to enhance its research and development in regenerative medicine. The move is expected to significantly boost their operational capabilities in this field.

Company Information

Company

HLB Innovation

Location

South Korea

About

HLB Innovation is a publicly traded company in South Korea and a member of the HLB Group. It has a diverse portfolio that spans biopharma, medical devices, healthcare, lifestyle, marine business, semiconductor, and energy, united by the mission of improving all aspects of human life.

Don't miss HLB Innovation's next move

Get an email the moment HLB Innovation makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for HLB Innovation's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired HLB Cell?

HLB Cell was acquired by HLB Innovation, based in South Korea. The deal was reported on September 9, 2026. HLB Innovation is a publicly traded company in South Korea and a member of the HLB Group. HLB Innovation is privately held and operates in Biotechnology.

When did HLB Innovation acquire HLB Cell?

HLB Innovation's acquisition of HLB Cell was reported on September 9, 2026. HLB Innovation has acquired HLB Cell to strengthen its domestic capabilities in cell therapy. This acquisition emphasizes HLB Innovation's commitment to advancing healthcare solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does HLB Cell do?

HLB Cell specializes in cell therapy and regenerative medicine. The company is dedicated to advancing therapeutic options for various diseases. They are known for their research and development in cellular treatments. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.